Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biofrontera (BFRI) Interest & Investment Income (2023 - 2025)

Biofrontera has reported Interest & Investment Income over the past 3 years, most recently at -$121000.0 for Q4 2025.

  • For Q4 2025, Interest & Investment Income fell 202.5% year-over-year to -$121000.0; the TTM value through Dec 2025 reached -$453000.0, up 77.74%, while the annual FY2025 figure was -$452000.0, 77.79% up from the prior year.
  • Interest & Investment Income for Q4 2025 was -$121000.0 at Biofrontera, down from -$111000.0 in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $56000.0 in Q1 2023 and troughed at -$1.4 million in Q1 2024.
  • A 3-year average of -$259250.0 and a median of -$113000.0 in 2025 define the central range for Interest & Investment Income.
  • On a YoY basis, Interest & Investment Income climbed as much as 105.63% in 2024 and fell as far as 2612.5% in 2024.
  • Year by year, Interest & Investment Income stood at -$579000.0 in 2023, then surged by 93.09% to -$40000.0 in 2024, then tumbled by 202.5% to -$121000.0 in 2025.
  • Business Quant data shows Interest & Investment Income for BFRI at -$121000.0 in Q4 2025, -$111000.0 in Q3 2025, and -$115000.0 in Q2 2025.